ATS 2024 Final Program

Click on the session title to view the speakers

42

SUNDAY • MAYs 19

P123 Impact of Race on Adverse Outcomes From Asthma: Survey Results P124 Future Exacerbation and Patterns in Asthma Medications Among Patients With a History of ER Visit-related Exacerbation a 5-year Retrospective Longitudinal Study P125 Revisits Study: Evaluating for Enrollment Bias Across Diverse US Hospitals P126 Effectiveness of a Virtual Patient Simulation at Improving Identification of Worsening COPD and Refferal for Endobronchial Valve Assessment P127 Clinical Pathways; Do They Make a Difference? P128 Racial Differences in End-of-Life Care Among Adults With Chronic Obstructive Pulmonary Disease P129 Examining Alignment of Patient Medication-taking Behaviors With Inhaler Usage Recommendations in Chronic Obstructive Pulmonary Disease and Asthma P130 Patterns in Patient and Provider Characteristics Over Time Among Patients Initiating Alpha-1 Proteinase Inhibitors P131 Observations From Real World Evidence: Uncovering Bias in Alpha-1 Antitrypsin Deficiency Testing P132 Comparison of 1-year Mortality Between Chronic Obstructive Pulmonary Disease (COPD) Vs Non-COPD Patients Undergoing Palliative Care P133 Association Between Serial Spirometric Improver Phenotype (Improved FEV1 Over Time) Versus Decliner Phenotype in Healthcare Utilization in Chronic Obstructive Pulmonary Disease P134 Hospitalizations for Respiratory Disease in Patients With Schizophrenia: Insights From a Large National Database in the United States P135 Evolution and Clinical Outcome of Small Airway Dysfunction (SAD) P136 Factors Predicting the Survival and the Type of Oxygen-Delivery Device Prescription in Long-term Oxygen Therapy Patients in France: A Nationwide Health Claims Database (SNDS) Study P137 Biologic Therapies for Moderate-to-Severe Asthma and Its Comorbidities: What Can Medical Education Reveal About Barriers to Their Adoption?

P138 Forecasting Cost and Hospitalization Reduction in COPD Care Through Monte Carlo Simulations With Use of an AI-driven Clinical Decision Support System P139 Enrollment in Hospice and Outcomes Following a COPD Hospitalization

BEHAVIORAL • CLINICAL THEMATIC POSTER SESSION

A36 PROGRESS IN LUNG CANCER AND LUNG CANCER SCREENING 9:15 a.m. - 4:15 p.m. Viewing: Posters will be on display for entire session Discussion: 11:30-12:30 Discussionwith facilitators, authors, andattendees 12:30-1:15 Authorswill beby their posters for individual discussionwithattendees P713 Elemental Assessment of Educational Videos on the Awareness and Preventive Role of Low-dose CT Scan for Early Diagnosis of Lung Cancer in Smoker Population P714 Prevalence, Trends, and Impact of Cannabis Use Disorder on Hospitalization Outcomes of Lung Cancer Patients: A Nationwide Perspective 2016-2020 P715 TiMeToAct: Text Messaging to Advance Lung Cancer Screening P716 Formative Development of a Population Management Approach to Engage High-benefit Veterans in Lung Cancer Screening P717 How to Improve Lung Cancer Screening Rates: Lessons From a University of Michigan Quality Improvement Initiative P718 Estimating Lung Cancer Screening Rates in a Large Academic Healthcare System P719 Disparities in Lung Cancer Screening Within an Integrated Healthcare System P720 Proposed Solutions to Improve Lung Cancer Screening Codesigned With Primary Care San Diego Convention Center Area G (Hall A-B2, Ground Level)

ATS 2024 Conference Program • San Diego, CA